OpenAI’s ChatGPT is a language processing artificial intelligence system that has the potential to provide excellent fertility advice, albeit with some limitations. Developed in November 2022, the model has acquired over 100 million users in two months since its launch. This prompted a study by Fertility and Sterility that sought to test ChatGPT’s performance for the purpose of accessing clinical information from fertility-oriented content.
The study found that the AI chatbot was able to reproduce facts as they were written on the United States Centers for Disease Control and Prevention (CDC) website – which was the first domain for testing. ChatGPT even scored high on the Cardiff Fertility Knowledge Scale (CFKS) and the Fertility and Infertility Treatment Knowledge Score (FIT-KS) surveys, the second domain of testing. On the third domain, which involved building the summary of the American Society for Reproductive Medicine (ASRM) Committee Opinion, ChatGPT reproduced all missing facts successfully.
Although hopeful, it is important to remember the limitation that while providing prompt responses, ChatGPT may utilize data from unreliable sources. This is why it is necessary to assess its performance continuously, as the volatile nature of technology may cause the model to produce inaccurate results. Further, with the emergence of Microsoft Bing, Google Bard, and other rival models, it is necessary to keep track of the constant changes and to ensure that ChatGPT is not being outpaced.
OpenAI is a technology company based in San Francisco that builds artificial intelligence software focused on developing autonomous machines, especially for robotics and translational research projects. Founded in 2015, OpenAI’s goal is to build safe artificial general intelligence that will positively impact humanity and healthcare. The company is led by Sam Altman, Greg Brockman, Ilya Sutskever, and other industry leaders.
The study of the potential of using OpenAI’s ChatGPT as a fertility advisor was led by Dr. Priyom Bose, Ph.D. and it was completed and reviewed by Benedette Cuffari, M.Sc. in May 25 2023. Cuffari is a graduate from New York University with a Master’s Degree in Bioinformatics and has a vast experience working in clinical and non-clinical roles within the medical healthcare industry. Cuffari has an expertise in understanding complex medical literature, holding research activities, consulting with organizations on medical related topics, and is a nutrition consultant.
